RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Titan Medical Stock

Titan Medical Stocks 2024

Titan Medical Stocks

116.84 M

Ticker

TMD.TO

ISIN

CA88830X8199

WKN

A2JN66

In 2024, Titan Medical had 116.84 M outstanding stocks, a 4.77% change from the 111.52 M stocks in the previous year.

The Titan Medical Stocks history

YEARNUMBER OF STOCKS (undefined USD)
2023116.84
2022111.52
2021108.44
202067.01
201930.69
201816.64
20177.9
20164.88
20153.48
20143.14
20132.34
20122.14
20111.81
20101.41
20091.11
20080.78
20070.54

Titan Medical shares outstanding

The number of shares was Titan Medical in 2023 — This indicates how many shares 116.841 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Titan Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Titan Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Titan Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Titan Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Titan Medical Aktienanalyse

What does Titan Medical do?

Titan Medical Inc is a company specialized in the development of robotic systems for minimally invasive procedures in the field of medicine. It was founded in 2008 in Toronto, Canada by Reiza Rayman and Dmitry Oleynikov. The main goal of Titan Medical was to revolutionize surgery by developing innovative systems that enable more precise, less invasive, and more effective medical treatments. The business model of Titan Medical is based on the development, manufacturing, and marketing of robotic systems for minimally invasive surgical procedures. The main area of focus for Titan Medical is the development and distribution of robotic systems for urological, gynecological, and endoscopic surgery. These systems contribute to improving patient treatment and speeding up recovery by operating more precisely and safely than traditional surgical methods. The flagship product of Titan Medical is the Sport-Surgery System (STS), specifically designed for sports medicine, orthopedics, and spinal surgery. The STS technology provides an enhanced view of the surgical field, reducing the risk of injuries and complications. The STS system by Titan Medical is unique and stands out for its wireless operation, compatibility with conventional instruments, and ability to integrate different imaging modalities. Another product offered by Titan Medical is the Single-Port version of the Sport-Surgery System. This system is the first robotic system capable of performing minimally invasive surgery through a single incision. The system offers faster recovery, reduces scarring, and potential complications. The Single-Port version by Titan Medical is a unique product in the market and has the potential to revolutionize the practice of minimally invasive surgery. Titan Medical operates research and development departments in Toronto, Canada, and Chapel Hill, North Carolina, USA. These departments work on the development of new technologies aimed at improving surgery and enhancing patients' quality of life. The company collaborates with universities and clinics to test and validate innovative technologies. Titan Medical aims to market its products worldwide. The company works with distribution partners and distributors in North America, Europe, Asia, and Australia to place its products in different markets. Titan Medical places particular emphasis on training and supporting its customers to ensure the maximum efficiency and effectiveness of its products. In 2014, Titan Medical went public and has been listed on the Toronto Stock Exchange and NASDAQ since then. The company has experienced strong growth in recent years and has become an innovative leader in robotic surgery. Titan Medical has received numerous awards and recognition for its innovative products and technologies, including the Innovation Technology Award and the Medical Device Excellence Award. Overall, Titan Medical is a company specialized in the development of robotic systems for minimally invasive surgery. The company aims to make surgical procedures safer and more precise while speeding up patient recovery. By collaborating with universities and clinics, Titan Medical continuously works on developing new technologies and products to push the boundaries of minimally invasive surgery and improve patient care. Titan Medical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Titan Medical's Shares Outstanding

Titan Medical's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Titan Medical’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Titan Medical’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Titan Medical’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Titan Medical stock

How many stocks are there of Titan Medical?

The current number of stocks of Titan Medical is 116.84 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Titan Medical are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Titan Medical evolved in recent years?

The number of shares of Titan Medical has increased by 4.77% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Titan Medical as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Titan Medical?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Titan Medical pay?

Over the past 12 months, Titan Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Titan Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Titan Medical?

The current dividend yield of Titan Medical is .

When does Titan Medical pay dividends?

Titan Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Titan Medical?

Titan Medical paid dividends every year for the past 0 years.

What is the dividend of Titan Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Titan Medical located?

Titan Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Titan Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Titan Medical from 7/11/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did Titan Medical pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of Titan Medical in the year 2023?

In the year 2023, Titan Medical distributed 0 USD as dividends.

In which currency does Titan Medical pay out the dividend?

The dividends of Titan Medical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Titan Medical

Our stock analysis for Titan Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Titan Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.